Articles

Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation

Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan;Juntendo University Graduate School of Medicine, Tokyo, Japan
Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan;Juntendo University Graduate School of Medicine, Tokyo, Japan;Department of Hematology, Kumamoto University Hospital, Kagoshima, Japan
Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan
Department of Hematology, Sasebo City General Hospital, The University of Tokyo, Japan
Department of Hematology/Oncology, Institute of Medical Science, The University of Tokyo, Japan
Department of Hematology, National Hospital Organization Kagoshima Medical Center, Okinawa
Department of Hematology, Heart-Life Hospital, Okinawa, Japan
Department of Hematology, Nagasaki University Hospital, Fukuoka, Japan
Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Department of Hematology, Oita Prefectural Hospital, Okinawa, Japan
Second Department of Internal Medicine, University of the Ryukyus, Okinawa, Japan
Department of Hematology, Toranomon Hospital, Tokyo, Japan
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
Juntendo University Graduate School of Medicine, Tokyo, Japan;Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
Department of Hematology, Nagasaki University Hospital, Fukuoka, Japan
Vol. 102 No. 7 (2017): July, 2017 https://doi.org/10.3324/haematol.2017.164996